• #T-Bio 2021
  • Oct. 28th – 29th
  • Shanghai China

Asia BioPharma Industry Innovation Summit 2021

0 +

Keynote
Speeches

0 +

Professional
Attendees

0 +

Featured
Booths

0 +

Biopharma
Enterprises

0 +

Media
Reports

Key words of the conference

Industry Regulations and Policy Support, Import Substitution and Domestic Innovation, Package Plans for Biopharmaceuticals Worldwide IND Application, AI-Designed Drugs, License In/Out, Multi-Center Clinical Development, End-to-End Biopharmaceutical Preparation and Declaration Platform, Domestically Produced Alternatives, Cell and Gene Therapy, Rare Diseases, CAR-T, TCR-T/TIL/CAR-NK, IVD, Innovative Drug Patent, Antibody, QbD, Bispecific Antibody, Claudin 18.2, ADC, Nanobody, Cell Characterization Analysis, AAV Process Development, CRISPR/CAS9, PDC, mRNA, Synthetic Biology, Oncolytic Virus


Forum Structure
Main Forum

l  Globalization of Innovative Biopharmaceutical Companies: Global Cooperative Development and License In/Out Selection Considerations

l  How Can AI Technology and Deep Learning Help Biopharmaceuticals Development?

l  Global Multi-Center Clinical Development Strategy and Trial Design Ideas for Biopharmaceuticals

l  Domestically Produced Alternatives for Biopharmaceutical Manufacturing Processes and Equipment

l  The Development Trend of Detection and in Vitro Diagnostic Precision Medicine and Its Future Development in China

l  Offensive and Defensive Battle for Innovative Drug Patent Layout




Sub-Forum I

Antibody Drug Research and Development

l  Difficulties and Pain Points of Antibody Drug Development from The Perspective of PI

l  Next Generation Antibodies: Bispecific Antibody Development Platform

l  Preparation Process Hard Points of Claudin 18.2 (CLDN 18.2) Targeting Drugs

l  Nanobody Construction of Targeting Bispecific Antibodies and Multispecific Antibodies




Sub-Forum II

Cell Therapy Innovation and Industrialization

l  Research Status of CAR-T Cell Therapy Based on Tumor Microenvironment

l  Cell Characterization Analysis from Phenotype to Genotype: Application of Single Cell Functional Characterization in The Development of Cell Therapy

l  Spot-Type Allogeneic NK Cell Manufacturing Platform and CAR-NK Technology

l  Customized Manufacturing Meets the Strategic Demands of In-Depth Cell Therapy Product Development




Sub-Forum III

Gene Therapy and Technology Frontier

l  What Are The Concerns of Global Big Pharma in The Direction of Gene Therapy Drugs?

l  From Lab to Market, How to Operate Gene Therapy with Success?

l  Research Progress of CRISPR/CAS9 Gene Editing Technology in Cell and Gene Therapy

l  AAV Process Development and Quality Research




Sub-Forum Ⅳ

Progress and Breakthroughs in Innovative Therapies

l  Design Principles and Research Progress of Peptide Drugs PDC Next-Generation Tumor Targeted Therapy Drugs

l  Research on Core Barriers of mRNA Therapeutic Tumor Vaccine

l  Progress of AAV Gene Therapy in The Field of Rare Diseases

l  Synthetic Biology Helps The Development of Gene Therapy Drugs


Who Should Attend

1-200603143J53S.jpg

Speakers

Shwen Gwee from Novartis
Likun Gong

Deputy Director of Drug Safety & Evaluation, Professor

Shanghai Institute of Medical Medica

Shwen Gwee from Novartis
Shaoxiong CHEN

General Secretary

Shanghai Biopharmaceutics Industry Association

Shwen Gwee from Novartis
Jijie Gu

EVP & CSO

WuXi Biologics

Shwen Gwee from Novartis
Michael Xie

VP of Analytics

Shanghai Henlius Biotech. Inc

Shwen Gwee from Novartis
Shuangqing Peng

Medicilon

Shwen Gwee from Novartis
Qi XU

vice President

Shanghai BiBo pharma scientific Co. Ltd.

Shwen Gwee from Novartis
Yi ZHU

China Head

T-Cure Bioscience Inc.

Shwen Gwee from Novartis
Naibo Yang

COO

GenoImmune Therapeutics, Ltd

Shwen Gwee from Novartis
Liang Zhang

Vice President

Bioray laboratories Inc.

Shwen Gwee from Novartis
Joe Zhou

President and CSO

Genor BioPharma

Shwen Gwee from Novartis
Changlin DOU

COO

Shandong Boan Biotechnology Co., Ltd.

Shwen Gwee from Novartis
Dan Li

Executive Vice President

Sinopharm Capital

Shwen Gwee from Novartis
Shanmei Liao

Stat lead for post approval, senior director

Beigene (Shanghai) Co., Ltd

Shwen Gwee from Novartis
Alex YE

VPGlobal Business Development

Adlai Nortye

Shwen Gwee from Novartis
Dr. Joan Shen

CEO

I-Mab Biopharma

Shwen Gwee from Novartis
Jery Li

The Leader of IBM GCG Watson Health

IBM Watson

Ways to Attend

Increase Your Visibility. Improve Your Reputation

Normal Ticket

  • 1 Pass

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs & Documentation


Exhibition Sponsor

  • 3 Passes

  • 6㎡or 9㎡ Booth for show

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Presentation Sponsor

(Slots Limits)

  • 5 Passes

  • 30 min Speech Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Gold Sponsor

(Exclusive)

  • 5 or More Passes

  • 30 min Speech Opportunity

  • 6or 9 Booth for show

  • Chairman Opportunity

  • 1 Color AD Page

  • Panelist Discussion

  • Holistic Logo Branding On-site

  • 2 Networking Buffet Lunch

  • Simultaneous Interpretation

  • PPTs& Documentation


Secure your ticket today

Early Bird tickets available now

Secure your spot at T-Bio 2021 with our special offer, and don’t go alone, enjoy the best group discount.

Register

Sponsors & Partners Previous Year

Co-Organizer

上海市生物医药行业协会

Bronze Sponsor

碧博生物

Presentation Sponsor

智慧芽
南翔

Exhibition Sponsor

安捷伦
海尔
美迪西
碧博生物
楚天源创
凯斯艾生物
诺唯赞
泰坦科技
奥盛仪器
凯莱英
诺坦普
迈百瑞
普瑞金
柏恒

Part of Media Partners

腾讯网
今日头条
搜狗
搜狐
凤凰网
红报网
网易
一点资讯
趣头条
研发客
肽度
大健康派
生物探索
药源网
药智论坛
第一健康管理网
现代健康网
医药健闻
中国制药设备网
环球财经
商业观察网
趣科技
美通社
动脉网
医疗器械创新网
人民医生网
医药行
化学+
中国仪器批发网
露森科研
基因线上
分析测试百科网
全球医学会议网

Related Meetings